References
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:https://doi.org/10.3322/caac.21492.
- Prakash I, Thomas SM, Greenup RA, et al. Time to surgery among women treated with neoadjuvant systemic therapy and upfront surgery for breast cancer. Breast Cancer Res Treat. 2021;186(2):535–550. doi:https://doi.org/10.1007/s10549-020-06012-7.
- Xiong H, Chen Z, Xu L, et al. Contrast of mastoscopic and conventional axillary lymph node dissection of patients with breast cancer: meta-analysis. Cancer Control. 2020;27(2):107327482093298. doi:https://doi.org/10.1177/1073274820932987.
- Yatim N, Cullen S, Albert ML. Dying cells actively regulate adaptive immune responses. Nat Rev Immunol. 2017;17:262–275. doi:https://doi.org/10.1038/nri.2017.9.
- Mamessier E, Sylvain A, Thibult M-L, et al. Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity. J Clin Invest. 2011;121:3609–3622. doi:https://doi.org/10.1172/JCI45816.
- Zhou J-B, Yang J-K, Zhao L, Xin Z. Variants in KCNQ1, AP3S1, MAN2A1, and ALDH7A1 and the risk of type 2 diabetes in the Chinese Northern Han population: a case-control study and meta-analysis. Med Sci Monit. 2010;16:BR179–BR183.
- Kim H-J, Cantor H. CD4 T-cell subsets and tumor immunity: the helpful and the not-so-helpful. Cancer Immunol Res. 2014;2:91–98. doi:https://doi.org/10.1158/2326-6066.CIR-13-0216.
- Carvalho MI, Pires I, Prada J, Queiroga FL. A role for T-lymphocytes in human breast cancer and in canine mammary tumors. Biomed Res Int. 2014;2014:130894. doi:https://doi.org/10.1155/2014/130894.
- Sung S-Y, Hsieh C-L, Wu D, Chung LWK, Johnstone PAS. Tumor microenvironment promotes cancer progression, metastasis, and therapeutic resistance. Curr Probl Cancer. 2007;31:36–100. doi:https://doi.org/10.1016/j.currproblcancer.2006.12.002.
- Choi J, Cha YJ, Koo JS. Adipocyte biology in breast cancer: from silent bystander to active facilitator. Prog Lipid Res. 2018;69:11–20. doi:https://doi.org/10.1016/j.plipres.2017.11.002.
- Park H-K, Ahima RS. Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism. Metabolism. 2015;64:24–34. doi:https://doi.org/10.1016/j.metabol.2014.08.004.
- Barone I, Giordano C, Bonofiglio D, Andò S, Catalano S. Leptin, obesity and breast cancer: progress to understanding the molecular connections. Curr Opin Pharmacol. 2016;31:83–89. doi:https://doi.org/10.1016/j.coph.2016.10.003.
- Niu J, Jiang L, Guo W, Shao L, Liu Y, Wang L. The association between leptin level and breast cancer: a meta-analysis. PLoS One. 2013;8:e67349. doi:https://doi.org/10.1371/journal.pone.0067349.
- Guo S, Liu M, Wang G, Torroella-Kouri M, Gonzalez-Perez RR. Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells. Biochim Biophys Acta. 2012;1825:207–222. doi:https://doi.org/10.1016/j.bbcan.2012.01.002.
- Dalamaga M, Diakopoulos KN, Mantzoros CS. The role of adiponectin in cancer: a review of current evidence. Endocr Rev. 2012;33:547–594. doi:https://doi.org/10.1210/er.2011-1015.
- Gu L, Cao C, Fu J, Li Q, Li D-H, Chen M-Y. Serum adiponectin in breast cancer: a meta-analysis. Medicine. 2018;97(29):e11433. doi:https://doi.org/10.1097/MD.0000000000011433.
- Andò S, Gelsomino L, Panza S, et al. Obesity, leptin and breast cancer: epidemiological evidence and proposed mechanisms. Cancers (Basel). 2019;11(1):62. doi:https://doi.org/10.3390/cancers11010062.
- Delort L, Rossary A, Farges M-C, Vasson M-P, Caldefie-Chézet F, et al. Leptin, adipocytes and breast cancer: focus on inflammation and anti-tumor immunity. Life Sci. 2015;140:37–48. doi:https://doi.org/10.1016/j.lfs.2015.04.012.
- Chinese Society of Breast Surgery, Chinese Surgical Society of Chinese Medical Association. Consensus statements and operation guidelines on endoscopic surgery for breast cancer. Zhonghua Wai Ke Za Zhi. 2020;58:257c260. doi:https://doi.org/10.3760/cma.j.cn112139-20200116-00034.
- Krall JA, Reinhardt F, Mercury OA, et al. The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy. Sci Transl Med. 2018;10(436):eaan3464. doi:https://doi.org/10.1126/scitranslmed.aan3464.
- Okholm C, Goetze JP, Svendsen LB, Achiam MP. Inflammatory response in laparoscopic vs. open surgery for gastric cancer. Scand J Gastroenterol. 2014;49:1027–1034. doi:https://doi.org/10.3109/00365521.2014.917698.
- Karanika S, Karantanos T, Theodoropoulos GE. Immune response after laparoscopic colectomy for cancer: a review. Gastroenterol Rep (Oxf.). 2013;1:85–94. doi:https://doi.org/10.1093/gastro/got014.
- Wu M-H, Wang M-Y, Yang C-Y, Lee P-H, Lin M-T. Inflammatory response attenuation in patients undergoing gasless laparoscopic gastrectomy. Hepatogastroenterology. 2013;60:439–442. doi:https://doi.org/10.5754/hge12944.
- Tai L-H, Tanese de Souza C, Sahi S, et al. A mouse tumor model of surgical stress to explore the mechanisms of postoperative immunosuppression and evaluate novel perioperative immunotherapies. J Vis Exp. 2014;85:e51253. doi:https://doi.org/10.3791/51253.
- Melamed R, Bar-Yosef S, Shakhar G, Shakhar K, Ben-Eliyahu S. Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesth Analg. 2003;97(5):1331–1339. doi:https://doi.org/10.1213/01.ane.0000082995.44040.07.
- Goldfarb Y, Sorski L, Benish M, Levi B, Melamed R, Ben-Eliyahu S. Improving postoperative immune status and resistance to cancer metastasis: a combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses. Ann Surg. 2011;253:798–810. doi:https://doi.org/10.1097/SLA.0b013e318211d7b5.
- Shakhar G, Ben-Eliyahu S. In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. J Immunol. 1998;160:3251–3258.
- Angka L, Khan ST, Kilgour MK, Xu R, Kennedy MA, Auer RC. Dysfunctional natural killer cells in the aftermath of cancer surgery. Int J Mol Sci. 2017;18(8):1787. doi:https://doi.org/10.3390/ijms18081787.
- Vandeweyer E, Hertens D. Quantification of glands and fat in breast tissue: an experimental determination. Ann Anat. 2002;184:181–184. doi:https://doi.org/10.1016/S0940-9602(02)80016-4.
- Alosco ML, Spitznagel MB, Strain G, et al. Improved serum leptin and ghrelin following bariatric surgery predict better postoperative cognitive function. J Clin Neurol. 2015;11:48–56. doi:https://doi.org/10.3988/jcn.2015.11.1.48.
- Florescu A, Branisteanu D, Bilha S, et al. Leptin and adiponectin dynamics at patients with rectal neoplasm - gender differences. PLoS One. 2019;14(8):e0212471. doi:https://doi.org/10.1371/journal.pone.0212471.